Full-Blown Agony: A Personal Struggle Against the Enigmatic Pain of Cluster Headache Syndrome
It began on a dreary Monday morning in the autumn of 2016. I worked as a educator, attempting to manage a new group of students, when a sharp sensation bloomed behind my right eye. This was followed by quick stabs, like lightning bolts. As each class came and went, the pain eased and then returned with increased intensity. Multiple times that day I handed over a teaching assistant with activities and ran to the school bathroom to soak my face with cold water. I took ibuprofen, but the pain remained unrelenting.
The headaches returned frequently that autumn, and again in the spring, soon forming an yearly pattern. The autumn months were the most severe, then February and March. I could predict the routine: aura in the morning, early pangs on the commute, full-blown agony in class by mid-morning. In late 2019, a doctor finally referred me to a neurologist and I was given a diagnosis with cluster headache disorder.
This condition often begin with intense discomfort behind a single eye that persists up to three hours.
Approximately 1 in 1000 people are affected by the condition, and males are more often affected. Attacks typically start with sudden, excruciating agony around one eye that reaches its peak within minutes and continues for up to three hours. Episodes come in clusters, every day or multiple times a day, and are accompanied by tearing eyes, drooping eyelids or facial sweating. There exists the episodic form, which arrives in periodic cycles; others have chronic attacks, characterized by the absence of extended pain-free periods.
What unites sufferers is the severity. One study scored the pain at 9.7 10, more severe than broken bones or pancreatitis. A separate found a significant percentage of cluster headache patients reported suicidal thoughts amid bouts; the figure fell to 4% when they were pain-free.
One patient, in her seventies, a long-term sufferer from Wales, finds this understandable. Her episodes began when she was a toddler. “I would hurl myself on the floor and hit my head. That was attributed to being spoiled,” she says. Her symptoms worsened through her youth. Alcohol in her adolescence, similar to many triggers, made things more intense. After having alcohol at her graduation party, she remembers hardly being able to see on the transport home.
Her relatives often mistook her episodes as intoxicated behavior. Support finally came from her parent and then from her partner, Rod. “I was very fortunate to find such an exceptional person,” she says. Hobbs found clerical work after moving, but often hid her illness. She was dismissed from one job, partly due to time off during episodes. Her breakthrough identification came in 2002 at a specialist neurology center.
Still, the inability to plan daily activities around unpredictable pain took its toll. She particularly hated being unable to plan outings, being seen as unreliable as a co-worker, and even having to be cared for by her children during the paralysis caused by the worst episodes. “It steals from you of the simple liberties we don't appreciate until they're gone,” she says. She remembers winning tickets for a major concert, only to have an episode inside a portable toilet.
Headaches have been described throughout the ages. “The first description of headache comes by way of the Mesopotamians in antiquity,” write authors in a publication on the topic. They linked the disease to an malevolent spirit who attacked his victims' heads.
Historical medical texts propose bizarre remedies for what modern observers would describe as a migraine. In the middle ages, severe headache was identified as a distinct condition, with therapies including bloodletting to other, more folk remedies.
It was a European physician who provided the initial comprehensive account of a cluster headache. In his medical observations, he speaks of a patient “suffering with a very severe headache happening and disappearing daily at fixed hours”.
The disorder were only formally classified by international medical societies in 1988. From the mid-20th century to the late 1990s, they were thought to be caused by a issue with a key artery which supplies blood to the head. Prominent specialists in diagnosing the disorder note this.
In the late 1990s, researchers published the findings of a study for which they had induced attacks in patients and observed the attacks in a imaging machine. The data, featured in a prominent medical publication, showed activation of the hypothalamus, which is responsible for human sleep-wake cycles, when patients were in pain, and a deactivation when they recovered.
In spite of such progress, identification remains slow. One man's attacks began in the 1980s and felt like “a balloon being blown up behind my one eye”. GPs thought he had a sinus issue; he had multiple operations before finally being correctly identified in 2014, after a physician looked up his complaints.
Neurologists say wait times in diagnosis and treatment occur because patients are rarely seen mid-attack. “You're exhausted and low, but not in severe pain,” a doctor says. He proceeds by eliminating other primary head pain conditions, such as migraine, before diagnosing the disorder. A thorough history is essential: on which part of the head do signs appear? For how much time? What time of year? Are there triggers, such as certain foods? Certain features such as tearing, sagging eyelids and stuffy nose help verify the diagnosis. Once identified, patients may be referred to dedicated clinics. But many first arrive to emergency rooms or are given inadequate treatments.
A charity trustee, 78, has suffered from cluster headaches for the majority of her adult life, although she hasn't had an attack since recent years. When she was in her 20s, she had her molars pulled because dental professionals misunderstood her pain. She thinks the dental profession still need much more awareness. When another patient sought help from a support group, it was she who replied. I remember calling a helpline during an attack in 2021; a reassuring advisor guided me through oxygen treatment and drugs until the episode passed.
Official guidelines on management advise that sufferers are offered high-flow oxygen and/or a anti-migraine drug delivered by nasal spray. No oral painkillers or opioids should be used. Preventive options include verapamil, which reportedly soothes the bouts of some individuals.
But consultant specialists argue the guidance need updating to reflect a clearer clinical pathway and help general practitioners avoid misprescribing. For episodic patients, the treatment window is everything: “The duration of the bout determines the approach.” Short bouts with occasional episodes are handled with acute therapy only. Longer or more intense bouts require preventative medications such as verapamil, sometimes paired with steroids. Many patients also receive a greater occipital nerve block during a cycle – an procedure into the side of the skull where the discomfort is that reduces nerve activity.
The national guidelines need revising to reflect a
